297 related articles for article (PubMed ID: 31148231)
1. p53 induces miR-199a-3p to suppress mechanistic target of rapamycin activation in cisplatin-induced acute kidney injury.
Yang A; Liu F; Guan B; Luo Z; Lin J; Fang W; Liu L; Zuo W
J Cell Biochem; 2019 Oct; 120(10):17625-17634. PubMed ID: 31148231
[TBL] [Abstract][Full Text] [Related]
2. miR-132-3p promotes the cisplatin-induced apoptosis and inflammatory response of renal tubular epithelial cells by targeting SIRT1 via the NF-κB pathway.
Han S; Lin F; Ruan Y; Zhao S; Yuan R; Ning J; Jiang K; Xie J; Li H; Li C; Rao T; Yu W; Xia Y; Zhou X; Cheng F
Int Immunopharmacol; 2021 Oct; 99():108022. PubMed ID: 34339961
[TBL] [Abstract][Full Text] [Related]
3. MiR-199a-3p enhances cisplatin sensitivity of cholangiocarcinoma cells by inhibiting mTOR signaling pathway and expression of MDR1.
Li Q; Xia X; Ji J; Ma J; Tao L; Mo L; Chen W
Oncotarget; 2017 May; 8(20):33621-33630. PubMed ID: 28422725
[TBL] [Abstract][Full Text] [Related]
4. p53 induces miR199a-3p to suppress SOCS7 for STAT3 activation and renal fibrosis in UUO.
Yang R; Xu X; Li H; Chen J; Xiang X; Dong Z; Zhang D
Sci Rep; 2017 Feb; 7():43409. PubMed ID: 28240316
[TBL] [Abstract][Full Text] [Related]
5. p53 activates miR-192-5p to mediate vancomycin induced AKI.
Chen J; Wang J; Li H; Wang S; Xiang X; Zhang D
Sci Rep; 2016 Dec; 6():38868. PubMed ID: 27941921
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-199a-3p regulates endometrial cancer cell proliferation by targeting mammalian target of rapamycin (mTOR).
Wu D; Huang HJ; He CN; Wang KY
Int J Gynecol Cancer; 2013 Sep; 23(7):1191-7. PubMed ID: 23851675
[TBL] [Abstract][Full Text] [Related]
7. p53 inhibition attenuates cisplatin-induced acute kidney injury through microRNA-142-5p regulating SIRT7/NF-κB.
Chen G; Xue H; Zhang X; Ding D; Zhang S
Ren Fail; 2022 Dec; 44(1):368-380. PubMed ID: 35220863
[TBL] [Abstract][Full Text] [Related]
8. hsa-miR-500a-3P alleviates kidney injury by targeting MLKL-mediated necroptosis in renal epithelial cells.
Jiang L; Liu XQ; Ma Q; Yang Q; Gao L; Li HD; Wang JN; Wei B; Wen J; Li J; Wu YG; Meng XM
FASEB J; 2019 Mar; 33(3):3523-3535. PubMed ID: 30365367
[TBL] [Abstract][Full Text] [Related]
9. Discovery of an integrative network of microRNAs and transcriptomics changes for acute kidney injury.
Lee CG; Kim JG; Kim HJ; Kwon HK; Cho IJ; Choi DW; Lee WH; Kim WD; Hwang SJ; Choi S; Kim SG
Kidney Int; 2014 Nov; 86(5):943-53. PubMed ID: 24759152
[TBL] [Abstract][Full Text] [Related]
10. LncRNA NEAT1 promotes hypoxia-induced renal tubular epithelial apoptosis through downregulating miR-27a-3p.
Jiang X; Li D; Shen W; Shen X; Liu Y
J Cell Biochem; 2019 Sep; 120(9):16273-16282. PubMed ID: 31090110
[TBL] [Abstract][Full Text] [Related]
11. Exosomes from human-bone-marrow-derived mesenchymal stem cells protect against renal ischemia/reperfusion injury via transferring miR-199a-3p.
Zhu G; Pei L; Lin F; Yin H; Li X; He W; Liu N; Gou X
J Cell Physiol; 2019 Dec; 234(12):23736-23749. PubMed ID: 31180587
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA26a inhibits cisplatin-induced renal tubular epithelial cells apoptosis through suppressing the expression of transient receptor potential channel 6 mediated dynamin-related protein 1.
Yang Y; Li ZL; Wang FM; Tang RN; Tu Y; Liu H
Cell Biochem Funct; 2020 Jun; 38(4):384-391. PubMed ID: 31887787
[TBL] [Abstract][Full Text] [Related]
13. miR-199a-3p is involved in estrogen-mediated autophagy through the IGF-1/mTOR pathway in osteocyte-like MLO-Y4 cells.
Fu J; Hao L; Tian Y; Liu Y; Gu Y; Wu J
J Cell Physiol; 2018 Mar; 233(3):2292-2303. PubMed ID: 28708244
[TBL] [Abstract][Full Text] [Related]
14. MiR-199a-3p enhances breast cancer cell sensitivity to cisplatin by downregulating TFAM (TFAM).
Fan X; Zhou S; Zheng M; Deng X; Yi Y; Huang T
Biomed Pharmacother; 2017 Apr; 88():507-514. PubMed ID: 28126676
[TBL] [Abstract][Full Text] [Related]
15. miR-199a-3p enhances cisplatin sensitivity of ovarian cancer cells by targeting ITGB8.
Cui Y; Wu F; Tian D; Wang T; Lu T; Huang X; Zhang P; Qin L
Oncol Rep; 2018 Apr; 39(4):1649-1657. PubMed ID: 29436681
[TBL] [Abstract][Full Text] [Related]
16. miR-338-3p confers 5-fluorouracil resistance in p53 mutant colon cancer cells by targeting the mammalian target of rapamycin.
Han J; Li J; Tang K; Zhang H; Guo B; Hou N; Huang C
Exp Cell Res; 2017 Nov; 360(2):328-336. PubMed ID: 28928082
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-199a-3p suppresses glioma cell proliferation by regulating the AKT/mTOR signaling pathway.
Shen L; Sun C; Li Y; Li X; Sun T; Liu C; Zhou Y; Du Z
Tumour Biol; 2015 Sep; 36(9):6929-38. PubMed ID: 25854175
[TBL] [Abstract][Full Text] [Related]
18. Exosomal miR-125b-5p deriving from mesenchymal stem cells promotes tubular repair by suppression of p53 in ischemic acute kidney injury.
Cao JY; Wang B; Tang TT; Wen Y; Li ZL; Feng ST; Wu M; Liu D; Yin D; Ma KL; Tang RN; Wu QL; Lan HY; Lv LL; Liu BC
Theranostics; 2021; 11(11):5248-5266. PubMed ID: 33859745
[TBL] [Abstract][Full Text] [Related]
19. Suppressing miR-199a-3p by promoter methylation contributes to tumor aggressiveness and cisplatin resistance of ovarian cancer through promoting DDR1 expression.
Deng Y; Zhao F; Hui L; Li X; Zhang D; Lin W; Chen Z; Ning Y
J Ovarian Res; 2017 Jul; 10(1):50. PubMed ID: 28743276
[TBL] [Abstract][Full Text] [Related]
20. Exosomes function as nanoparticles to transfer miR-199a-3p to reverse chemoresistance to cisplatin in hepatocellular carcinoma.
Zhang K; Shao CX; Zhu JD; Lv XL; Tu CY; Jiang C; Shang MJ
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32463473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
